"Helpnic: US FDA approval and recurring consumables sales expected to expand"
Predicted impact: Low· Actual: −3.6% vs sector, volume 1.5× normal (5 trading days)
FDA approval expectations for a small company; no approval date or size confirmed.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.